دورية أكاديمية
[Low-intensity extracorporeal shock wave treatment improves erectile function in non-responder PDEi5 patients: A systematic review].
| العنوان: | [Low-intensity extracorporeal shock wave treatment improves erectile function in non-responder PDEi5 patients: A systematic review]. |
|---|---|
| عنوان ترانسليتريتد: | Ondas de choque de baja intensidad para la mejora en el tratamiento de la disfunción eréctil en pacientes no respondedores a PDE5-i: revisión sistemática. |
| المؤلفون: | Grandez-Urbina JA; Universidad Continental, Lima, Perú. Electronic address: jagrandez@gmail.com., Rodríguez RP; Centro de Investigación, Clínica de Urología Avanzada UROZEN, Lima, Perú; Instituto de Investigación en Ciencias Biomédicas, Universidad Ricardo Palma, Lima, Perú., Torres-Román JS; Centro de Investigación, Clínica de Urología Avanzada UROZEN, Lima, Perú., Saldaña-Gallo J; Centro de Investigación, Clínica de Urología Avanzada UROZEN, Lima, Perú., García-Perdomo HA; Departamento de Cirugía/Urología, Escuela de Medicina, Universidad del Valle, Cali, Colombia. |
| المصدر: | Revista internacional de andrologia [Rev Int Androl] 2021 Oct-Dec; Vol. 19 (4), pp. 272-280. Date of Electronic Publication: 2020 Jun 27. |
| نوع المنشور: | Journal Article; Review; Systematic Review |
| اللغة: | Spanish; Castilian |
| بيانات الدورية: | Publisher: Elsevier Doyma Country of Publication: Spain NLM ID: 101500934 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1698-0409 (Electronic) Linking ISSN: 1698031X NLM ISO Abbreviation: Rev Int Androl Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Barcelona : Elsevier Doyma |
| مواضيع طبية MeSH: | Extracorporeal Shockwave Therapy*, Erectile Dysfunction/*therapy , Penile Erection/*physiology, Humans ; Male ; Penile Erection/drug effects ; Phosphodiesterase 5 Inhibitors/therapeutic use ; Treatment Outcome |
| مستخلص: | Objective: To determine the effectiveness and safety in the short, medium, and long term of LISWT in patients with Erectile Dysfunction who do not respond to PDE5 inhibitors. Methodology: Clinical study, quasi-experimental cohort and systematic review following the guidelines of the Cochrane collaboration and the PRISMA writing guides. The measurement of the variables was determined as a primary outcome to the evaluation of erectile function, by means of a validated questionnaire. The baseline scale was evaluated, as well as the difference at 1, 3 and 6 months, evidenced by the possibility of maintaining an erection or responding to therapy with PDEi5. An information search was carried out from its beginning to the current date, in the databases: Medline, Embase, Central, Science Direct and Lilacs. Results: The studies found used different outcome variables to show efficacy in the follow-up: All the studies used the IIEF-EF as outcome variable in its different variations. Conclusion: LISWT could be an effective and safe treatment in patients not responding to PDEi5. It is important to point out that the evidence is currently limited, randomized studies with greater methodological rigidity and follow-up longer than 12 months are needed in order to verify the medium and long-term effect of the application of shock waves in this group of patients. (Copyright © 2020 Asociación Española de Andrología, Medicina Sexual y Reproductiva. Publicado por Elsevier España, S.L.U. All rights reserved.) |
| فهرسة مساهمة: | Keywords: Disfunción eréctil; Erectile dysfunction; Nitric oxide; PDE5; iPDE5; Óxido nítrico |
| المشرفين على المادة: | 0 (Phosphodiesterase 5 Inhibitors) |
| تواريخ الأحداث: | Date Created: 20200702 Date Completed: 20220124 Latest Revision: 20220124 |
| رمز التحديث: | 20231215 |
| DOI: | 10.1016/j.androl.2020.04.004 |
| PMID: | 32605764 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1698-0409 |
|---|---|
| DOI: | 10.1016/j.androl.2020.04.004 |